Risk factors and outcomes for the Q151M and T69 insertion HIV-1 resistance mutations in historic UK data-Reference-Cited by-同舟云学术

Risk factors and outcomes for the Q151M and T69 insertion HIV-1 resistance mutations in historic UK data

Published:2018-04-16 Issue:1 Volume:15 Page:
ISSN:1742-6405
Container-title:AIDS Research and Therapy
language:en
Short-container-title:AIDS Res Ther

Author:

Stirrup Oliver T.^ORCID, ,Dunn David T.,Tostevin Anna,Sabin Caroline A.,Pozniak Anton,Asboe David,Cox Alison,Orkin Chloe,Martin Fabiola,Cane Patricia,

Funder

Medical Research Council

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Virology,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12981-018-0198-7.pdf

Reference35 articles.

1. UK HIV Drug Resistance Database. HIV drug resistance in the UK. 2017. http://www.hivrdb.org.uk/hiv-drug-resistance-uk . Accessed 13 Sept 2017.

2. Rocheleau G, Brumme CJ, Shoveller J, Lima V, Harrigan P. Longitudinal trends of HIV drug resistance in a large Canadian cohort, 1996–2016. Clin Microbiol Infect. 2018;24:185–91.

3. De Luca A, Dunn D, Zazzi M, Camacho R, Torti C, Fanti I, et al. Declining prevalence of HIV-1 drug resistance in antiretroviral treatment-exposed individuals in Western Europe. J Infect Dis. 2013;207:1216–20.

4. Scherrer AU, von Wyl V, Yang W-L, Kouyos RD, Böni J, Yerly S, et al. Emergence of acquired HIV-1 drug resistance almost stopped in Switzerland: a 15-year prospective cohort analysis. Clin Infect Dis. 2016;62:1310–7.

5. Ssemwanga D, Lihana RW, Ugoji C, Al Abimiku, Nkengasong J, Dakum P, et al. Update on HIV-1 acquired and transmitted drug resistance in Africa. AIDS Rev. 2015;17:3–20.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human Immunodeficiency Virus-1 Subtype-C Genetically Diversify to Acquire Higher Replication Competence in Human Host with Comorbidities;AIDS Research and Human Retroviruses;2021-05-01

2. First Assessment of Acquired HIV-1 Drug Resistance and Mutation Patterns in Suriname;AIDS Research and Human Retroviruses;2021-01-12

3. Continuation of emtricitabine/lamivudine within combination antiretroviral therapy following detection of the M184V/I HIV‐1 resistance mutation;HIV Medicine;2020-01-11